计算机断层扫描灌注成像用于监测肝细胞癌经动脉化疗栓塞
这项前瞻性双中心研究纳入24例肝细胞癌患者,在DEB-TACE前后行灌注CT,测量动脉肝灌注、门静脉灌注和肝灌注指数。DEB-TACE后动脉肝灌注和肝灌注指数与疗效分级相关,识别完全缓解的AUC分别为0.74和0.80。DEB-TACE后早期高动脉灌注和低门静脉灌注提示不完全缓解,诊断准确性良好。
要点
- DEB-TACE后早期高动脉灌注和低门静脉灌注提示不完全缓解,诊断准确性良好。
- DEB-TACE后动脉肝灌注和肝灌注指数与疗效分级相关,识别完全缓解的AUC分别为0.74和0.80。
- DEB-TACE前后动脉肝灌注、门静脉灌注和肝灌注指数的平均变化分别为-55%、+24%和-27%。
核心结论
- DEB-TACE后早期肝细胞癌高动脉灌注和低门静脉灌注提示不完全缓解,诊断准确性良好。
研究设计与样本
- 前瞻性双中心研究,纳入24例(54-79岁)接受DEB-TACE的肝细胞癌患者,在DEB-TACE前后行灌注CT,由两名读者在匹配的兴趣区内测定动脉肝灌注、门静脉灌注和肝灌注指数,以影像随访确定治疗反应并区分完全与不完全缓解者。
诊断标准与关键数值
- DEB-TACE后动脉肝灌注和肝灌注指数与疗效分级相关(r=0.45/0.48;均p<0.04),识别完全缓解的AUC分别为0.74和0.80。
临床应用与阅片要点
- DEB-TACE后早期灌注CT显示高动脉灌注和低门静脉灌注提示不完全缓解;DEB-TACE前门静脉灌注在经治疗病灶与未治疗病灶间差异显著(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To prospectively monitor changes in tumor perfusion of hepatocellular carcinoma (HCC) in response to doxorubicin-eluted bead based transarterial chemoembolization (DEB-TACE) using perfusion-CT (P-CT).
METHODS AND MATERIALS: 24 patients (54-79 years) undergoing P-CT before and shortly after DEB-TACE of HCC were prospectively included in this dual-center study. Two readers determined arterial-liver-perfusion (ALP, mL/min/100mL), portal-venous-perfusion (PLP, mL/min/100mL) and the hepatic-perfusion-index (HPI, %) by placing matched regions-of-interests within each HCC before and after DEB-TACE. Imaging follow-up was used to determine treatment response and to distinguish complete from incomplete responders. Performance of P-CT for prediction and early response assessment was determined using receiver-operating-characteristics curve analysis.
RESULTS: Interreader agreement was fair to excellent (ICC, 0.716-0.942). PLP before DEB-TACE was significantly higher in pre-treated vs non-treated lesions (P<0.05). Mean changes of ALP, PLP and HPI from before to after DEB-TACE were -55%, +24% and -27%. ALP and HPI after DEB-TACE were correlating with response-grades (r=0.45/0.48; both, p<0.04), showing an area-under-the-curve (AUC) of 0.74 and 0.80 respectively for identification of complete response.
CONCLUSION: High arterial and low portal-venous perfusion of HCC early after DEB-TACE indicates incomplete response with good diagnostic accuracy.
引用
- Marquez HP, Karalli A, Haubenreisser H, et al. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. Eur J Radiol. 2017. PMID: 28629564. doi:10.1016/j.ejrad.2017.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。